Skip to main content

Advertisement

SpringerLink
Log in

Approach to Dysphagia in the Young Patient in the Era of Eosinophilic Esophagitis

  • Published:
Current Gastroenterology Reports Aims and scope Submit manuscript

Abstract

Eosinophilic esophagitis (EoE) has emerged as an important cause of dysphagia and food impactions in young adults. Previously considered a rare condition, an increasing number of cases of EoE have been attributable to a rising incidence and a growing awareness of the condition. Typical endoscopic features include concentric mucosal rings, linear furrowing, white exudates, and a narrow caliber esophagus. Current consensus guidelines define EoE by 1) the presence of characteristic symptoms, especially dysphagia and food impactions in adults, 2) ≥ 15 eosinophils per high power field in esophageal tissue, and 3) exclusion of other disorders with similar presentations (eg, gastroesophageal reflux disease). Current knowledge about the pathophysiology implicates food allergens, aeroallergens, and genetic factors. The main treatment options for EoE are proton pump inhibitors, dietary manipulation, and topical or oral glucocorticoids. Endoscopic dilation may be performed in patients who do not respond to medical therapy. This review highlights recent insights into the diagnosis and management of EoE in young adults.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Rothenberg ME: Pathogenesis and clinical features of eosinophilic esophagitis. J Allergy Clin Immunol 2001, 108:891–894.

    Article  CAS  PubMed  Google Scholar 

  2. Croese J, Fairley SK, Masson JW, et al.: Clinical and endoscopic features of eosinophilic esophagitis in adults. Gastrointest Endosc 2003, 58:516–522.

    Article  PubMed  Google Scholar 

  3. Straumann A, Spichtin HP, Grize L, et al.: Natural history of primary eosinophilic esophagitis: a follow-up of 30 adult patients for up to 11.5 years. Gastroenterology 2003, 125:1660–1669.

    Article  PubMed  Google Scholar 

  4. Fox VL, Nurko S, Furuta GT: Eosinophilic esophagitis: it’s not just kid’s stuff. Gastrointest Endosc 2002, 56:260–270.

    Article  PubMed  Google Scholar 

  5. Cheung KM, Oliver MR, Cameron DJ, et al.: Esophageal eosinophilia in children with dysphagia. J Pediatr Gastroenterol Nutr 2003, 37:498–503.

    Article  PubMed  Google Scholar 

  6. Noel RJ, Putnam PE, Rothenberg ME: Eosinophilic esophagitis. N Engl J Med 2004, 351:940–941.

    Article  CAS  PubMed  Google Scholar 

  7. Straumann A, Simon HU: Eosinophilic esophagitis: escalating epidemiology? J Allergy Clin Immunol 2005, 115:418–419.

    Article  PubMed  Google Scholar 

  8. Prasad GA, Alexander JA, Schleck CD, et al.: Epidemiology of eosinophilic esophagitis over three decades in Olmsted County, Minnesota. Clin Gastroenterol Hepatol 2009, 7:1055–1061.

    Article  PubMed  Google Scholar 

  9. Veerappan GR, Perry JL, Duncan TJ, et al.: Prevalence of eosinophilic esophagitis in an adult population undergoing upper endoscopy: a prospective study. Clin Gastroenterol Hepatol 2009, 7:420–426, 426 e1–2.

    Google Scholar 

  10. Kugathasan S, Judd RH, Hoffmann RG, et al.: Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population-based study. J Pediatr 2003, 143:525–531.

    Article  PubMed  Google Scholar 

  11. •• Furuta GT, Liacouras CA, Collins MH, et al.: Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology 2007, 133:1342–1363. This systematic review provides a comprehensive evaluation of the current literature and evidence-based recommendations for the diagnosis and management of adults and children with eosinophilic esophagitis.

  12. Sgouros SN, Bergele C, Mantides A: Eosinophilic esophagitis in adults: a systematic review. Eur J Gastroenterol Hepatol 2006, 18:211–217.

    Article  PubMed  Google Scholar 

  13. Assa’ad A, Putnam PE, Collins MH, et al.: Eosinophilic esophagitis: association with allergic disorders. Gastrointest Endosc Clin N Am 2008, 18:119–132; x.

    Google Scholar 

  14. Gonsalves N, Policarpio-Nicolas M, Zhang Q, et al.: Histopathologic variability and endoscopic correlates in adults with eosinophilic esophagitis. Gastrointest Endosc 2006, 64:313–319.

    Article  PubMed  Google Scholar 

  15. Morrow JB, Vargo JJ, Goldblum JR, et al.: The ringed esophagus: histological features of GERD. Am J Gastroenterol 2001, 96:984–989.

    Article  CAS  PubMed  Google Scholar 

  16. Zimmerman SL, Levine MS, Rubesin SE, et al.: Idiopathic eosinophilic esophagitis in adults: the ringed esophagus. Radiology 2005, 236:159–165.

    Article  PubMed  Google Scholar 

  17. Liacouras CA, Spergel JM, Ruchelli E, et al.: Eosinophilic esophagitis: a 10-year experience in 381 children. Clin Gastroenterol Hepatol 2005, 3:1198–1206.

    Article  PubMed  Google Scholar 

  18. Parfitt, JR, Gregor JC, Suskin NG, et al.: Eosinophilic esophagitis in adults: distinguishing features from gastroesophageal reflux disease: a study of 41 patients. Mod Pathol 2006, 19:90–96.

    Article  PubMed  Google Scholar 

  19. Aceves SS, Newbury RO, Dohil R, et al.: Esophageal remodeling in pediatric eosinophilic esophagitis. J Allergy Clin Immunol 2007, 119:206–212.

    Article  CAS  PubMed  Google Scholar 

  20. Chehade M, Sampson HA, Morotti RA, et al.: Esophageal subepithelial fibrosis in children with eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 2007, 45:319–328.

    Article  PubMed  Google Scholar 

  21. Shah A, Kagalwalla A, Gonsalves N, et al.: Histopathologic variability in children with eosinophilic esophagitis. Am J Gastroenterol 2009, 104:716–721.

    Article  PubMed  Google Scholar 

  22. Mishra A, Hogan SP, Brandt EB, et al.: An etiological role for aeroallergens and eosinophils in experimental esophagitis. J Clin Invest 2001, 107:83–90.

    Article  CAS  PubMed  Google Scholar 

  23. Fogg MI, Ruchelli E, Spergel JM: Pollen and eosinophilic esophagitis. J Allergy Clin Immunol 2003, 112:796–797.

    Article  PubMed  Google Scholar 

  24. Wang FY, Gupta SK, Fitzgerald JF: Is there a seasonal variation in the incidence or intensity of allergic eosinophilic esophagitis in newly diagnosed children? J Clin Gastroenterol 2007, 41:451–453.

    Article  PubMed  Google Scholar 

  25. Kelly KJ, Kazenby AJ, Rowe PC, et al.: Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula. Gastroenterology 1995, 109:1503–1512.

    Article  CAS  PubMed  Google Scholar 

  26. Kagalwalla AF, Sentengo TA, Ritz S, et al.: Effect of six-food elimination diet on clinical and histologic outcomes in eosinophilic esophagitis. Clin Gastroenterol Hepatol 2006, 4:1097–1102.

    Article  PubMed  Google Scholar 

  27. Spergel JM, Beausoleil JL, Mascarenhas M, et al.: The use of skin prick tests and patch tests to identify causative foods in eosinophilic esophagitis. J Allergy Clin Immunol 2002, 109:363–368.

    Article  PubMed  Google Scholar 

  28. Gonsalves N, Yang G, Doerfler B, et al.: A prospective clinical trial of six food elimination diet and reintroduction of causative agents in adults with eosinophilic esophagitis. Gastroenterology 2008, 134:A104.

    Article  Google Scholar 

  29. Mishra A, Hogan SP, Brandt EB, et al.: IL-5 promotes eosinophil trafficking to the esophagus. J Immunol 2002, 168:2464–2469.

    CAS  PubMed  Google Scholar 

  30. Mishra A, Rothenberg ME: Intratracheal IL-13 induces eosinophilic esophagitis by an IL-5, eotaxin-1, and STAT6-dependent mechanism. Gastroenterology 2003, 125:1419–1427.

    Article  CAS  PubMed  Google Scholar 

  31. Mishra A, Wang M, Pemmaraju VR, et al.: Esophageal remodeling develops as a consequence of tissue specific IL-5-induced eosinophilia. Gastroenterology 2008, 134:204–214.

    Article  PubMed  Google Scholar 

  32. Gupta SK, Fitzgerald JF, Kondratyuk T, et al.: Cytokine expression in normal and inflamed esophageal mucosa: a study into the pathogenesis of allergic eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 2006, 42:22–26.

    Article  CAS  PubMed  Google Scholar 

  33. Simon D, Marti H, Heer P, et al.: Eosinophilic esophagitis is frequently associated with IgE-mediated allergic airway diseases. J Allergy Clin Immunol 2005, 115:1090–1092.

    Article  PubMed  Google Scholar 

  34. Patel SM, Falchuk KR: Three brothers with dysphagia caused by eosinophilic esophagitis. Gastrointest Endosc 2005, 61:165–167.

    Article  PubMed  Google Scholar 

  35. Meyer GW: Eosinophilic esophagitis in a father and a daughter. Gastrointest Endosc 2005, 61:932.

    Article  PubMed  Google Scholar 

  36. Zink DA, Amin M, Gebara S, et al.: Familial dysphagia and eosinophilia. Gastrointest Endosc 2007, 65:330–4.

    Article  PubMed  Google Scholar 

  37. • Blanchard C, Wang N, Stringer KF, et al.: Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest 2006, 116:536–547. This article describes pivotal research investigating the genetic factors behind EoE and demonstrating a signature gene-expression profile that differentiates patients with EoE from those with GERD.

  38. Lucendo AJ, Navarro M, Comas C, et al.: Treatment with topical steroids downregulates IL-5, eotaxin-1/CCL11, and eotaxin-3/CCL26 gene expression in eosinophilic esophagitis.. Am J Gastroenterol 2008, 103:2184–2193.

    Article  CAS  PubMed  Google Scholar 

  39. Bhattacharya B, Carlsten J, Sabo E., et al.: Increased expression of eotaxin-3 distinguishes between eosinophilic esophagitis and gastroesophageal reflux disease. Hum Pathol 2007, 38:1744–1753.

    Article  CAS  PubMed  Google Scholar 

  40. Wolfsen HC, Hemminger LL, Achem SR: Eosinophilic esophagitis and Barrett’s esophagus with dysplasia. Clin Gastroenterol Hepatol 2007, 5:A18.

    Article  PubMed  Google Scholar 

  41. Dranove JE, Horn DS, Davis MA, et al.: Predictors of response to proton pump inhibitor therapy among children with significant esophageal eosinophilia. J Pediatr 2009,154:96–100.

    Article  CAS  PubMed  Google Scholar 

  42. Garrean CP, Zhang Q, Gonsalves N, et al.: Acid reflux detection and symptom-reflux association using 4-day wireless pH recording combining 48-hour periods off and on PPI therapy. Am J Gastroenterol 2008, 103:1631–1637.

    Article  PubMed  Google Scholar 

  43. Ngo P, Furuta GT, Antonioli DA, et al.: Eosinophils in the esophagus--peptic or allergic eosinophilic esophagitis? Case series of three patients with esophageal eosinophilia. Am J Gastroenterol 2006, 101:1666–1670.

    Article  PubMed  Google Scholar 

  44. Liacouras CA, Wenner WJ, Brown K, et al.: Primary eosinophilic esophagitis in children: successful treatment with oral corticosteroids. J Pediatr Gastroenterol Nutr 1998, 26:380–385.

    Article  CAS  PubMed  Google Scholar 

  45. Arora AS, Perrault J, Smyrk TC, et al.: Topical corticosteroid treatment of dysphagia due to eosinophilic esophagitis in adults. Mayo Clin Proc 2003, 78:830–835.

    Article  CAS  PubMed  Google Scholar 

  46. Remedios M, Campbell C, Jones DM, et al.: Eosinophilic esophagitis in adults: clinical, endoscopic, histologic findings, and response to treatment with fluticasone propionate. Gastrointest Endosc 2006, 63:3–12.

    Article  PubMed  Google Scholar 

  47. Lucendo AJ, Pascual-Turrion JM, Navarro M, et al.: Endoscopic, bioptic, and manometric findings in eosinophilic esophagitis before and after steroid therapy: a case series. Endoscopy 2007, 39:765–771.

    Article  CAS  PubMed  Google Scholar 

  48. Konikoff MR, Noel RJ, Blanchard C, et al.: A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis. Gastroenterology 2006, 131:1381–1391.

    Article  CAS  PubMed  Google Scholar 

  49. Aceves SS, Bastian JF, Newbury RO, et al.: Topical viscous budesonide suspension for treatment of eosinophilic esophagitis. J Allergy Clin Immunol 2005, 116:705–706.

    Article  CAS  PubMed  Google Scholar 

  50. Straumann A, Felder S, Bussman C, et al.: Budesonide as induction treatment for active eosinophilic esophagitis in adolescents and adults: A randomized, double blind, placebo controlled study (BEE-I Trial). Gastroenterology 2008, 134:A726.

    Google Scholar 

  51. Attwood SE, Smyrk TC, Demeester TR, et al.: Eosinophilic oesophagitis: a novel treatment using Montelukast. Gut 2003, 52:181–185.

    Article  CAS  PubMed  Google Scholar 

  52. Stein ML, Collins MH, Villanueva JM, et al.: Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis. J Allergy Clin Immunol 2006, 118:1312–1319.

    Article  CAS  PubMed  Google Scholar 

  53. Straumann A, Conus S, Grzonka P, et al.: Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial. Gut 2010, 59:21–30.

    Article  CAS  PubMed  Google Scholar 

  54. Foroughi S, Foster B, Kim N, et al.: Anti-IgE treatment of eosinophil-associated gastrointestinal disorders. J Allergy Clin Immunol 2007, 120:594–601.

    Article  CAS  PubMed  Google Scholar 

  55. Straumann A, Bussman C, Conus S, et al.: Anti-TNF-alpha (infliximab) therapy for severe adult eosinophilic esophagitis. J Allergy Clin Immunol 2008, 122:425–427.

    Article  CAS  PubMed  Google Scholar 

  56. Netzer P, Gschossmann JM, Straumann A, et al.: Corticosteroid-dependent eosinophilic oesophagitis: azathioprine and 6-mercaptopurine can induce and maintain long-term remission. Eur J Gastroenterol Hepatol 2007, 19:865–869.

    Article  CAS  PubMed  Google Scholar 

  57. Cohen MS, Kaufman AB, Palazzo JP, et al.: An audit of endoscopic complications in adult eosinophilic esophagitis. Clin Gastroenterol Hepatol 2007, 5:1149–1153.

    Article  PubMed  Google Scholar 

  58. Eisenbach C, Merle U, Schirmacher P, et al.: Perforation of the esophagus after dilation treatment for dysphagia in a patient with eosinophilic esophagitis. Endoscopy 2006, 38(Suppl 2):E43– E44.

    Article  PubMed  Google Scholar 

  59. Schoepfer AM, Gonsalves N, Bussman C, et al.: Esophageal dilation in eosinophilic esophagitis: effectiveness, safety, and impact on the underlying inflammation. Am J Gastroenterol 2009 (Epub ahead of print).

  60. Hirano I, Gonsalves N, Ditto A: Eosinophilic esophagitis. In Patterson's Allergic Diseases. Edited by Grammer L, Greenberger P. Philadelphia, PA: Lippincott Williams & Wilkins; 2009:633–646.

Download references

Disclosure

No potential conflict of interest relevant to this article was reported.

Author information

Authors and Affiliations

  1. Department of Medicine, Division of Gastroenterology, Northwestern University, Feinberg School of Medicine, 676 St Clair St, Suite 1400, Chicago, IL, 60611-2951, USA

    Nirmala Gonsalves

Authors
  1. Nirmala Gonsalves
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nirmala Gonsalves.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gonsalves, N. Approach to Dysphagia in the Young Patient in the Era of Eosinophilic Esophagitis. Curr Gastroenterol Rep 12, 181–188 (2010). https://doi.org/10.1007/s11894-010-0101-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11894-010-0101-8

Keywords

Search

Navigation